The relationship between Gastric cancer (GC) and various risk factors is well-established, but the relationship between use of cholesterol-lowering prescription medications and GC remains controversial. This study aimed to investigate further the association between the two utilizing the National Health and Nutrition Examination Survey (NHANES) database. In this study, the NHANES database (1999-2018) was utilized to explore the association between the use of cholesterol-lowering prescription medications and GC. Baseline characteristics were first outlined using data from NHANES, followed by association analysis, risk stratification analysis, and receiver operating characteristic (ROC) analysis. Baseline statistical results indicated that the use of cholesterol-lowering prescription medications was significantly associated with GC, both as an independent exposure factor and after adjusting for various covariates. The results of risk stratification analysis showed a significant positive correlation between the use of cholesterol-lowering prescription medications and GC (odds ratio (OR) = 1.73, 95% confidence intervals (CI) = 1.07-2.8, p < 0.05). Additionally, ROC analysis result indicated that use of cholesterol-lowering prescription medications was a risk predictor for GC and could relatively accurately distinguish between GC patients and non-GC patients (AUC = 0.799). GC was associated with cholesterol, and use of cholesterol-lowering prescription medications was a risk predictor for GC. This provides valuable insights for future research.

NO authors have competing interests

The author(s) received no specific funding for this work.

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

N/A

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes